The federal government presented on Tuesday the first details of the National Vaccination Plan against COVID-19 in Mexico , in which medical personnel fighting the pandemic and older adults will have priority to receive the dose. Hugo López-Gatell , Undersecretary of Health, pointed out that the application of the doses against the SARS-CoV2-2 virus will follow this prioritization scheme.
1. Health workers
2. People aged 80 or over
3. People from 70 to 79 years old
4. People from 60 to 69 years old
5. People from 50 to 59 years old
6. People from 40 to 49 years old
7. Population under 40 years old
The first phase of vaccination , which runs from December 2020 to February 2021, includes professionals who care for the pandemic. In the next phase (February to April 2021) , health personnel who were not included in the previous stage and people aged 60 and over would be vaccinated.
In the third stage (between April and May 2021) people between 50 and 59 years old would be immunized, while in the next stage people between 40 and 49 years old would be vaccinated, between May and June of next year.
Stage 5 of the vaccination campaign will include the rest of the population and is projected to start in June 2021 and run until March 2022.
Health authorities expect that 250,000 doses of the vaccine created between Pfizer and BioNTech will arrive in Mexico this month, while, according to Foreign Minister Marcelo Ebrard, another 15 million doses would be sent to our country during the first four months of 2021.
López-Gatell commented that, following the recommendations of the Government’s technical advisory group, people who already suffered from COVID-19 would also have to receive the injection against the pathogen.
“They should also be considered because because this is a new virus and there is still information on the duration of immunity, the type and the strength of the immunity that is not known in detail, ” he commented.
In addition to the purchase agreement with Pfizer, the Government of Mexico has also signed one with AstraZeneca and it is expected that in the next few days Jorge Alcocer, Secretary of Health, will sign one more with CanSino Biologics. This company is currently conducting the phase 3 trial in various entities of the Mexican Republic.